Published in Genes Dev on August 01, 1991
Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev (2000) 9.36
Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol Cell Biol (2000) 8.89
Genome-wide MyoD binding in skeletal muscle cells: a potential for broad cellular reprogramming. Dev Cell (2010) 4.50
Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol Cell Biol (1997) 3.62
Discrimination between related DNA sites by a single amino acid residue of Myc-related basic-helix-loop-helix proteins. Proc Natl Acad Sci U S A (1992) 3.25
Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc Natl Acad Sci U S A (1996) 3.24
p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol Cell Biol (2000) 2.96
The muscle regulatory factors MyoD and myf-5 undergo distinct cell cycle-specific expression in muscle cells. J Cell Biol (1998) 2.50
Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C. Mol Cell Biol (1996) 2.40
Global and gene-specific analyses show distinct roles for Myod and Myog at a common set of promoters. EMBO J (2006) 2.38
TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev (2001) 2.35
Computational analysis of tissue-specific combinatorial gene regulation: predicting interaction between transcription factors in human tissues. Nucleic Acids Res (2006) 2.26
p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. EMBO J (1997) 2.05
Serum-regulated transcription by serum response factor (SRF): a novel role for the DNA binding domain. EMBO J (1994) 2.04
Notch inhibition of E47 supports the existence of a novel signaling pathway. Mol Cell Biol (1998) 1.99
Regulation of insulin-like growth factor-dependent myoblast differentiation by Foxo forkhead transcription factors. J Cell Biol (2003) 1.94
A heterodimer of HEB and an E12-related protein interacts with the CD4 enhancer and regulates its activity in T-cell lines. Mol Cell Biol (1993) 1.89
Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol Cell Biol (1994) 1.88
An overview of the basic helix-loop-helix proteins. Genome Biol (2004) 1.85
Multiple roles for the MyoD basic region in transmission of transcriptional activation signals and interaction with MEF2. Mol Cell Biol (1998) 1.82
The Enhancer of split [E(spl)] locus of Drosophila encodes seven independent helix-loop-helix proteins. Proc Natl Acad Sci U S A (1992) 1.76
Characterization of the transcription activation function and the DNA binding domain of transcriptional enhancer factor-1. EMBO J (1993) 1.68
NeuroD2 and neuroD3: distinct expression patterns and transcriptional activation potentials within the neuroD gene family. Mol Cell Biol (1996) 1.67
Muscle LIM protein promotes myogenesis by enhancing the activity of MyoD. Mol Cell Biol (1997) 1.66
The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation. Genes Dev (2000) 1.59
Interaction between acetylated MyoD and the bromodomain of CBP and/or p300. Mol Cell Biol (2001) 1.56
The basic domain of myogenic basic helix-loop-helix (bHLH) proteins is the novel target for direct inhibition by another bHLH protein, Twist. Mol Cell Biol (1997) 1.56
Codependent activators direct myoblast-specific MyoD transcription. Dev Cell (2008) 1.52
MyoD induces myogenic differentiation through cooperation of its NH2- and COOH-terminal regions. J Cell Biol (2005) 1.51
Histone methyltransferase Suv39h1 represses MyoD-stimulated myogenic differentiation. EMBO J (2006) 1.47
Radical acceleration of nuclear reprogramming by chromatin remodeling with the transactivation domain of MyoD. Stem Cells (2011) 1.46
The basic region of myogenin cooperates with two transcription activation domains to induce muscle-specific transcription. Mol Cell Biol (1992) 1.44
DNA binding and transcriptional regulatory activity of mammalian achaete-scute homologous (MASH) proteins revealed by interaction with a muscle-specific enhancer. Proc Natl Acad Sci U S A (1992) 1.43
MyoR: a muscle-restricted basic helix-loop-helix transcription factor that antagonizes the actions of MyoD. Proc Natl Acad Sci U S A (1999) 1.39
Functional specificity of the Antennapedia homeodomain. Proc Natl Acad Sci U S A (1993) 1.39
Molecular distinction between specification and differentiation in the myogenic basic helix-loop-helix transcription factor family. Mol Cell Biol (2001) 1.39
Different regulatory sequences control creatine kinase-M gene expression in directly injected skeletal and cardiac muscle. Mol Cell Biol (1993) 1.38
Helix-loop-helix proteins LYL1 and E2a form heterodimeric complexes with distinctive DNA-binding properties in hematolymphoid cells. Mol Cell Biol (1996) 1.35
Point mutations in the Drosophila hairy gene demonstrate in vivo requirements for basic, helix-loop-helix, and WRPW domains. Mol Cell Biol (1992) 1.35
Alteration of a single serine in the basic domain of the Epstein-Barr virus ZEBRA protein separates its functions of transcriptional activation and disruption of latency. J Virol (1997) 1.35
The hedgehog regulated oncogenes Gli1 and Gli2 block myoblast differentiation by inhibiting MyoD-mediated transcriptional activation. Oncogene (2006) 1.32
A point mutation in the MyoD basic domain imparts c-Myc-like properties. Proc Natl Acad Sci U S A (1992) 1.32
Definition of the transcriptional activation domain of recombinant 43-kilodalton USF. Mol Cell Biol (1992) 1.31
E Proteins and Id2 converge on p57Kip2 to regulate cell cycle in neural cells. Mol Cell Biol (2006) 1.31
Regulation of the rapsyn promoter by kaiso and delta-catenin. Mol Cell Biol (2004) 1.22
Molecular evolution of the MyoD family of transcription factors. Proc Natl Acad Sci U S A (1994) 1.19
Ras p21Val inhibits myogenesis without altering the DNA binding or transcriptional activities of the myogenic basic helix-loop-helix factors. Mol Cell Biol (1995) 1.16
Positive control mutations in the MyoD basic region fail to show cooperative DNA binding and transcriptional activation in vitro. Proc Natl Acad Sci U S A (1994) 1.16
E1A-mediated inhibition of myogenesis correlates with a direct physical interaction of E1A12S and basic helix-loop-helix proteins. Mol Cell Biol (1993) 1.13
Casein kinase II increases the transcriptional activities of MRF4 and MyoD independently of their direct phosphorylation. Mol Cell Biol (1996) 1.13
In vivo interactions of the Drosophila Hairy and Runt transcriptional repressors with target promoters. EMBO J (1996) 1.12
Determination of the DNA sequence recognized by the bHLH-zip domain of the N-Myc protein. Nucleic Acids Res (1992) 1.11
MyoD synergizes with the E-protein HEB beta to induce myogenic differentiation. Mol Cell Biol (2006) 1.11
Establishment of distinct MyoD, E2A, and twist DNA binding specificities by different basic region-DNA conformations. Mol Cell Biol (2000) 1.11
Artificial recruitment of TFIID, but not RNA polymerase II holoenzyme, activates transcription in mammalian cells. Mol Cell Biol (2000) 1.10
Structure and functions of powerful transactivators: VP16, MyoD and FoxA. Int J Dev Biol (2010) 1.09
Differences between MyoD DNA binding and activation site requirements revealed by functional random sequence selection. Mol Cell Biol (1996) 1.09
Sox15 is required for skeletal muscle regeneration. Mol Cell Biol (2004) 1.04
Fibroblast growth factor inhibits MRF4 activity independently of the phosphorylation status of a conserved threonine residue within the DNA-binding domain. Mol Cell Biol (1993) 1.04
Determinants of myogenic specificity within MyoD are required for noncanonical E box binding. Mol Cell Biol (2007) 1.02
A novel basic helix-loop-helix protein is expressed in muscle attachment sites of the Drosophila epidermis. Mol Cell Biol (1994) 1.01
Acetylation is important for MyoD function in adult mice. EMBO Rep (2006) 1.01
Co-operativity of functional domains in the muscle-specific transcription factor Myf-5. EMBO J (1992) 1.00
Trans-activation and DNA-binding properties of the transcription factor, Sox-18. Nucleic Acids Res (1995) 1.00
Sodium butyrate inhibits myogenesis by interfering with the transcriptional activation function of MyoD and myogenin. Mol Cell Biol (1992) 1.00
MyoD directly up-regulates premyogenic mesoderm factors during induction of skeletal myogenesis in stem cells. J Biol Chem (2010) 0.98
Beta-catenin regulates myogenesis by relieving I-mfa-mediated suppression of myogenic regulatory factors in P19 cells. Proc Natl Acad Sci U S A (2005) 0.98
E-box- and MEF-2-independent muscle-specific expression, positive autoregulation, and cross-activation of the chicken MyoD (CMD1) promoter reveal an indirect regulatory pathway. Mol Cell Biol (1994) 0.98
The MRF4 activation domain is required to induce muscle-specific gene expression. Mol Cell Biol (1992) 0.98
HES6 acts as a transcriptional repressor in myoblasts and can induce the myogenic differentiation program. J Cell Biol (2001) 0.96
MyoD and myogenin act on the chicken myosin light-chain 1 gene as distinct transcriptional factors. Mol Cell Biol (1993) 0.96
MyoD uses overlapping but distinct elements to bind E-box and tetraplex structures of regulatory sequences of muscle-specific genes. Nucleic Acids Res (2007) 0.95
Increased myogenic repressor Id mRNA and protein levels in hindlimb muscles of aged rats. Am J Physiol Regul Integr Comp Physiol (2002) 0.94
Intramolecular regulation of MyoD activation domain conformation and function. Mol Cell Biol (1998) 0.92
MyoD induced cell cycle arrest is associated with increased nuclear affinity of the Rb protein. Mol Biol Cell (1993) 0.92
Basic helix-loop-helix proteins in murine type C retrovirus transcriptional regulation. J Virol (1994) 0.89
Genomic editing tools to model human diseases with isogenic pluripotent stem cells. Stem Cells Dev (2014) 0.89
A cell-specific factor represses stimulation of transcription in vitro by transcriptional enhancer factor 1. Mol Cell Biol (1994) 0.89
TFIID (TBP) stabilizes the binding of MyoD to its DNA site at the promoter and MyoD facilitates the association of TFIIB with the preinitiation complex. Nucleic Acids Res (1998) 0.89
Identification of a neural-specific cDNA, NPDC-1, able to down-regulate cell proliferation and to suppress transformation. Proc Natl Acad Sci U S A (1995) 0.87
Retinoic acid induces myogenin synthesis and myogenic differentiation in the rat rhabdomyosarcoma cell line BA-Han-1C. J Cell Biol (1992) 0.87
Preferential MyoD homodimer formation demonstrated by a general method of dominant negative mutation employing fusion with a lysosomal protease. J Cell Biol (1996) 0.86
Identification of a novel function for the chromatin remodeling protein ING2 in muscle differentiation. PLoS One (2012) 0.86
c-jun inhibits insulin control element-mediated transcription by affecting the transactivation potential of the E2A gene products. Mol Cell Biol (1995) 0.85
Transcriptional analysis of the titin cap gene. Mol Genet Genomics (2011) 0.85
Dimerization through the helix-loop-helix motif enhances phosphorylation of the transcription activation domains of myogenin. Mol Cell Biol (1994) 0.84
Transcription of MyoD and myogenin in the non-contractile electrogenic cells of the weakly electric fish, Sternopygus macrurus. Dev Genes Evol (2004) 0.83
Structure of a dominant-negative helix-loop-helix transcriptional regulator suggests mechanisms of autoinhibition. EMBO J (2012) 0.83
SWI/SNF enzymes promote SOX10- mediated activation of myelin gene expression. PLoS One (2013) 0.82
Identification of two regulatory binding sites which confer myotube specific expression of the mono-ADP-ribosyltransferase ART1 gene. BMC Mol Biol (2008) 0.82
Distinct Activities of Myf5 and MyoD Indicate Separate Roles in Skeletal Muscle Lineage Specification and Differentiation. Dev Cell (2016) 0.81
Myocardin: dominant driver of the smooth muscle cell contractile phenotype. Arterioscler Thromb Vasc Biol (2008) 0.80
Zebrafish models of rhabdomyosarcoma. Methods Cell Biol (2011) 0.78
Characterization of muscle-regulatory gene, MyoD, from flounder (Paralichthys olivaceus) and analysis of its expression patterns during embryogenesis. Mar Biotechnol (NY) (2006) 0.78
A novel E1A domain mediates skeletal-muscle-specific enhancer repression independently of pRB and p300 binding. Mol Cell Biol (1996) 0.78
Administration of a soluble activin type IIB receptor promotes the transplantation of human myoblasts in dystrophic mice. Cell Transplant (2012) 0.77
A muscle stem cell for every muscle: variability of satellite cell biology among different muscle groups. Front Aging Neurosci (2015) 0.77
FGF2 mediates hepatic progenitor cell formation during human pluripotent stem cell differentiation by inducing the WNT antagonist NKD1. Genes Dev (2015) 0.77
Potential of adipose-derived stem cells in muscular regenerative therapies. Front Aging Neurosci (2015) 0.77
A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature (1997) 10.14
Heterologous protection against influenza by injection of DNA encoding a viral protein. Science (1993) 10.14
The myoD gene family: nodal point during specification of the muscle cell lineage. Science (1991) 9.53
The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem (2000) 7.41
Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci U S A (1989) 7.19
Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein. Science (1995) 6.25
The MyoD family and myogenesis: redundancy, networks, and thresholds. Cell (1993) 6.24
Xenopus embryos regulate the nuclear localization of XMyoD. Genes Dev (1994) 4.77
JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev (1994) 4.50
Positive autoregulation of the myogenic determination gene MyoD1. Cell (1989) 4.28
Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study. Lancet (2001) 4.12
Generation of neurons by transient expression of neural bHLH proteins in mammalian cells. Development (2000) 3.96
Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments. Development (2001) 3.79
Expression of two myogenic regulatory factors myogenin and MyoD1 during mouse embryogenesis. Nature (1989) 3.73
Y-Chromosome evidence for a northward migration of modern humans into Eastern Asia during the last Ice Age. Am J Hum Genet (1999) 3.60
Functional antagonism between c-Jun and MyoD proteins: a direct physical association. Cell (1992) 3.55
Modeling stochastic gene expression: implications for haploinsufficiency. Proc Natl Acad Sci U S A (1998) 3.49
MyoD binds cooperatively to two sites in a target enhancer sequence: occupancy of two sites is required for activation. Proc Natl Acad Sci U S A (1990) 3.14
Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum Mol Genet (2000) 3.07
CTCF-binding sites flank CTG/CAG repeats and form a methylation-sensitive insulator at the DM1 locus. Nat Genet (2001) 2.93
Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. J Biol Chem (2000) 2.92
Gender gap in cystic fibrosis mortality. Am J Epidemiol (1997) 2.74
An efficient and robust statistical modeling approach to discover differentially expressed genes using genomic expression profiles. Genome Res (2001) 2.63
The process of infection with Bacteriophage phi-X174. XXIX. In vivo studies on the synthesis of the single-stranded DNA of progeny phi-X174 bacteriophage. J Mol Biol (1969) 2.59
De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines. Proc Natl Acad Sci U S A (1990) 2.42
c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol Cell Biol (1994) 2.41
Two domains of MyoD mediate transcriptional activation of genes in repressive chromatin: a mechanism for lineage determination in myogenesis. Genes Dev (1997) 2.40
A peripheral blood diagnostic test for acute rejection in renal transplantation. Am J Transplant (2012) 2.25
Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers. Am J Physiol Endocrinol Metab (2001) 2.24
The discovery of potent cRaf1 kinase inhibitors. Bioorg Med Chem Lett (2000) 2.22
The MCK enhancer contains a p53 responsive element. Proc Natl Acad Sci U S A (1991) 2.16
Designing studies of computer-based alerts and reminders. MD Comput (1995) 2.15
Pediatric evidence-based medicine: past, present, and future. J Pediatr (2000) 2.06
Establishment of two human prostate cancer cell lines derived from a single bone metastasis. Clin Cancer Res (1997) 2.02
Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor beta-mediated signaling. J Biol Chem (1997) 2.00
Selective accumulation of MyoD and myogenin mRNAs in fast and slow adult skeletal muscle is controlled by innervation and hormones. Development (1993) 1.94
Taxol induces postmitotic myoblasts to assemble interdigitating microtubule-myosin arrays that exclude actin filaments. J Cell Biol (1981) 1.94
Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology. EMBO J (2001) 1.93
GermOnline, a cross-species community knowledgebase on germ cell differentiation. Nucleic Acids Res (2004) 1.90
A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. N Engl J Med (1991) 1.89
Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood (2000) 1.87
Phosphorylation of the C terminus of Fos protein is required for transcriptional transrepression of the c-fos promoter. Nature (1990) 1.81
Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP. Nat Genet (1997) 1.79
Multicenter epidemiologic and health services research on therapeutics in the HMO Research Network Center for Education and Research on Therapeutics. Pharmacoepidemiol Drug Saf (2002) 1.79
The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways. J Biol Chem (2000) 1.77
Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy. Proc Natl Acad Sci U S A (1998) 1.76
Prevalence of postnatal psychiatric morbidity in mothers and fathers. Br J Psychiatry (1994) 1.73
Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme. N Engl J Med (1979) 1.73
A basis for a visual language for describing, archiving and analyzing functional models of complex biological systems. Genome Biol (2001) 1.72
Intermediate-size filaments: changes in synthesis and distribution in cells of the myogenic and neurogenic lineages. Cold Spring Harb Symp Quant Biol (1982) 1.71
Autologous blood collection service. Med J Aust (1994) 1.70
Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme. Proc Natl Acad Sci U S A (1998) 1.70
Electron microscopic localization of acetylcholinesterase and nonspecific cholinesterase at the neuromuscular junction by the gold-thiocholine and gold-thiolacetic acid methods. J Cell Biol (1967) 1.69
Intermediate filament proteins in the developing chick spinal cord. Dev Biol (1981) 1.69
Transcatheter closure of atrial septal defects. Experimental studies. Circulation (1989) 1.68
Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection. Sarcoidosis Vasc Diffuse Lung Dis (2011) 1.68
MyoD and Myf-5 differentially regulate the development of limb versus trunk skeletal muscle. Development (1997) 1.68
NeuroD2 and neuroD3: distinct expression patterns and transcriptional activation potentials within the neuroD gene family. Mol Cell Biol (1996) 1.67
Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. Am J Epidemiol (1997) 1.63
Triplet repeat expansion in myotonic dystrophy alters the adjacent chromatin structure. Proc Natl Acad Sci U S A (1995) 1.60
Negative and positive regulation by transcription factor cAMP response element-binding protein is modulated by phosphorylation. Proc Natl Acad Sci U S A (1990) 1.60
Computer-based consultations in clinical therapeutics: explanation and rule acquisition capabilities of the MYCIN system. Comput Biomed Res (1975) 1.59
A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404. Int J Radiat Oncol Biol Phys (1999) 1.58
What scientists funded by the tobacco industry believe about the hazards of cigarette smoking. Am J Public Health (1991) 1.56
Solar neutrinos: a scientific puzzle. Science (1976) 1.56
Purified I kappa B-beta is inactivated upon dephosphorylation. J Biol Chem (1992) 1.50
The regulation of MyoD gene expression: conserved elements mediate expression in embryonic axial muscle. Dev Biol (1995) 1.50
The association between greater continuity of care and timely measles-mumps-rubella vaccination. Am J Public Health (2000) 1.49
Cyclists should wear helmets. BMJ (1997) 1.49
Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man. Circulation (1979) 1.47
Minor head injury in children: current management practices of pediatricians, emergency physicians, and family physicians. Arch Pediatr Adolesc Med (1998) 1.47
Tissue-specific expression of a type I adenylyl cyclase rescues the rutabaga mutant memory defect: in search of the engram. Learn Mem (2000) 1.46
Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells. J Biol Chem (1998) 1.45
Development of an antimicrobial susceptibility surveillance system for Neisseria gonorrhoeae in Malawi: comparison of methods. J Clin Microbiol (1997) 1.45
High-risk myocardial infarction patients appear to derive more mortality benefit from short door-to-balloon time than low-risk patients. Int J Clin Pract (2009) 1.45
Mice deficient in Six5 develop cataracts: implications for myotonic dystrophy. Nat Genet (2000) 1.44
Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy. Clin Pharmacol Ther (1986) 1.44
Requirement of the mouse I-mfa gene for placental development and skeletal patterning. EMBO J (1998) 1.43
Monoclonal antibodies to the myogenic regulatory protein MyoD1: epitope mapping and diagnostic utility. Cancer Res (1992) 1.43
MAPK activation determines renal epithelial cell survival during oxidative injury. Am J Physiol (1999) 1.42
Molecular distinction between specification and differentiation in the myogenic basic helix-loop-helix transcription factor family. Mol Cell Biol (2001) 1.39
Id: a negative regulator of helix-loop-helix DNA binding proteins. Control of terminal myogenic differentiation. Ann N Y Acad Sci (1990) 1.39
Screening--sensitivity, specificity and hepatitis C. Med J Aust (1996) 1.38
Design considerations for AIDS trials. N Engl J Med (1990) 1.38
NeuroD2 is necessary for development and survival of central nervous system neurons. Dev Biol (2001) 1.36
In vivo transcription of R-plasmid deoxyribonucleic acid in Escherichia coli strains with altered antibiotic resistance levels and/or conjugal proficiency. J Bacteriol (1976) 1.34
Positron emission tomography in the early diagnosis of Huntington's disease. Neurology (1986) 1.33
A conserved motif N-terminal to the DNA-binding domains of myogenic bHLH transcription factors mediates cooperative DNA binding with pbx-Meis1/Prep1. Nucleic Acids Res (1999) 1.32
Structure of the Tie2 RTK domain: self-inhibition by the nucleotide binding loop, activation loop, and C-terminal tail. Structure (2000) 1.32
Isolation of a microsporidian from a human patient. J Infect Dis (1990) 1.27
Quantitation of the RNA polymerase II transcription machinery in yeast. J Biol Chem (2001) 1.27